DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Dickson MA, Tap WA, Keohan ML, D'Angelo Sp, Gounder MM, Antonescu CR. et al.
phase II trial of the CDK4 inhibitor pD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
J Clin Oncol 2013;
31: 2024-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.